High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic.
Saved in:
| Title: | High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic. |
|---|---|
| Authors: | Upton DH; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Liu J; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., George SM; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Valvi S; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Ung C; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Rayner BS; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Gopalakrishnan A; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Pandher R; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Khan A; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Venkat P; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Mayoh C; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Holliday H; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Yeung N; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Nguyen H; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Franshaw L; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Ehteda A; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Shen H; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Farruggia G; Alma Mater Studiorum University of Bologna, Department of Pharmacy and Biotechnology, Bologna, Italy., Orienti I; Alma Mater Studiorum University of Bologna, Department of Pharmacy and Biotechnology, Bologna, Italy., Reynolds CP; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA., Tsoli M; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia., Ziegler DS; Kid's Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia. |
| Source: | Neuro-oncology [Neuro Oncol] 2025 Sep 08; Vol. 27 (7), pp. 1813-1828. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39935375 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Upton+DH%22">Upton DH</searchLink>; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22George+SM%22">George SM</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Valvi+S%22">Valvi S</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Ung+C%22">Ung C</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Rayner+BS%22">Rayner BS</searchLink>; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Gopalakrishnan+A%22">Gopalakrishnan A</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Pandher+R%22">Pandher R</searchLink>; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Khan+A%22">Khan A</searchLink>; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Venkat+P%22">Venkat P</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Mayoh+C%22">Mayoh C</searchLink>; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Holliday+H%22">Holliday H</searchLink>; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Yeung+N%22">Yeung N</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Nguyen+H%22">Nguyen H</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Franshaw+L%22">Franshaw L</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Ehteda+A%22">Ehteda A</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Shen+H%22">Shen H</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Farruggia+G%22">Farruggia G</searchLink>; Alma Mater Studiorum University of Bologna, Department of Pharmacy and Biotechnology, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Orienti+I%22">Orienti I</searchLink>; Alma Mater Studiorum University of Bologna, Department of Pharmacy and Biotechnology, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Reynolds+CP%22">Reynolds CP</searchLink>; Cancer Center, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.<br /><searchLink fieldCode="AU" term="%22Tsoli+M%22">Tsoli M</searchLink>; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22Ziegler+DS%22">Ziegler DS</searchLink>; Kid's Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.; School of Clinical Medicine, University of New South Wales, Sydney, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100887420%22">Neuro-oncology</searchLink> [Neuro Oncol] 2025 Sep 08; Vol. 27 (7), pp. 1813-1828. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100887420 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1523-5866 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215228517%22">15228517 </searchLink><i>NLM ISO Abbreviation: </i>Neuro Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39935375 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/neuonc/noaf035 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1813 Titles: – TitleFull: High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Upton DH – PersonEntity: Name: NameFull: Liu J – PersonEntity: Name: NameFull: George SM – PersonEntity: Name: NameFull: Valvi S – PersonEntity: Name: NameFull: Ung C – PersonEntity: Name: NameFull: Rayner BS – PersonEntity: Name: NameFull: Gopalakrishnan A – PersonEntity: Name: NameFull: Pandher R – PersonEntity: Name: NameFull: Khan A – PersonEntity: Name: NameFull: Venkat P – PersonEntity: Name: NameFull: Mayoh C – PersonEntity: Name: NameFull: Holliday H – PersonEntity: Name: NameFull: Yeung N – PersonEntity: Name: NameFull: Nguyen H – PersonEntity: Name: NameFull: Franshaw L – PersonEntity: Name: NameFull: Ehteda A – PersonEntity: Name: NameFull: Shen H – PersonEntity: Name: NameFull: Farruggia G – PersonEntity: Name: NameFull: Orienti I – PersonEntity: Name: NameFull: Reynolds CP – PersonEntity: Name: NameFull: Tsoli M – PersonEntity: Name: NameFull: Ziegler DS IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 09 Text: 2025 Sep 08 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1523-5866 Numbering: – Type: volume Value: 27 – Type: issue Value: 7 Titles: – TitleFull: Neuro-oncology Type: main |
| ResultId | 1 |